This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Stocks With Upgrades: CRL, CCJ, SVM, ACM, TPX, FLIR

NEW YORK ( TheStreet) -- Shares of these companies were upgraded to buy at TheStreet Ratings on Wednesday: Charles River Laboratories (CRL - Get Report), Cameco (CCJ - Get Report), Silvercorp Metals (SVM - Get Report), Aecom Technology (ACM), Tempur-Pedic (TPX - Get Report) and FLIR Systems (FLIR - Get Report).

Charles River Laboratories

The research company reported on Monday fourth-quarter earnings of $27.1 million, or 55 cents a share, a swing from a year-earlier loss of $342.4 million, or $5.94 a share.

"Our checks indicate more closures of pharma GLP Tox facilities are on the horizon. These should signal higher demand for outsourced services," Jefferies analysts wrote in a report Tuesday. "However, that has been the story for 3 years now. Low pricing still signals excess. Perhaps pharma is finally shuttering these labs after prolonged and unsuccessful attempts to sell them to CROs."

Shares of Charles River Laboratories were upgraded to buy from hold by TheStreet Ratings.

"The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins," TheStreet Ratings wrote. "We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself."

Charles River Laboratories has an estimated price-to-earnings ratio for next year of 11.93; the average for biotechnology companies is 28.35. For comparison, United Therapeutics (UTHR) has a lower forward P/E of 6.31 and Techne's (TECH) forward P/E is 20.16.

Of the 18 analysts who cover Charles River Laboratories, 14 rated the company a hold. Three analysts gave it a buy rating and one gave it a sell.

TheStreet Ratings gives Charles River Laboratories a B grade with a $39.15 price target. The stock closed Tuesday at $35.23 and has risen 28.91% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACM $32.10 0.85%
CCJ $12.50 2.30%
CRL $78.14 2.10%
FLIR $30.54 -0.06%
TPX $80.70 1.50%


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs